연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
2245. Resveratrol as a Tumor-Suppressive Nutraceutical Modulating Tumor Microenvironment and Malignant Behaviors of Cancer.
Han Y1,2, Jo H3,4, Cho JH5, Dhanasekaran DN6, Song YS7,8,9
Int J Mol Sci. 2019 Feb 20;20(4). pii: E925. doi: 10.3390/ijms20040925.
Link
2244. Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells.
Han Y1,2, Kim B2,3, Cho U2,4, Park IS2,5, Kim SI6, Dhanasekaran DN7, Tsang BK8,9, Song YS10,11,12,13.
Oncogene. 2019 Nov;38(45):7089-7105. doi: 10.1038/s41388-019-0949-5. Epub 2019 Aug 13.
Link
2243. Development of a patient-derived xenograft model of glioblastoma via intravitreal injection in mice.
Lee J1, Jo DH2,3, Kim JH2,3, Cho CS2,3, Han JE1, Kim Y1, Park H1, Yoo SH2, Yu YS2,4, Moon HE1, Park HR1, Kim DG1,5, Kim JH6,7,8,9, Paek SH10,11,12,13.
Exp Mol Med. 2019 Apr 16;51(4):43. doi: 10.1038/s12276-019-0241-3.
Link
2242. A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy.
Yi HG1, Jeong YH2, Kim Y3, Choi YJ4,5, Moon HE3, Park SH6, Kang KS7, Bae M1, Jang J8,9, Youn H10, Paek SH11, Cho DW12.
Nat Biomed Eng. 2019 Jul;3(7):509-519. doi: 10.1038/s41551-019-0363-x. Epub 2019 Mar 18.
Link
2241. Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer.
Lee KY1, Park JW2,3, Lee KY1, Cho S1, Kwon YH1, Kim MJ1, Ryoo SB1, Jeong SY1,4, Park KJ1.
Sci Rep. 2019 Aug 14;9(1):11846. doi: 10.1038/s41598-019-48197-y.
Link
2240. Oncologic outcomes after adjuvant chemotherapy with capecitabine compared to 5-fluorouracil/leucovorin for geriatric stage II colon cancer: a retrospective cohort study.
Lee KY1, Park JW2,3, Lee KY1, Cho S1, Kwon YH1, Kim MJ1, Ryoo SB1, Jeong SY1,4, Park KJ1.
Int J Colorectal Dis. 2019 Apr;34(4):629-639. doi: 10.1007/s00384-019-03237-x. Epub 2019 Jan 19.
Link
2239. Safety of temporary ileostomy via specimen extraction site in rectal cancer patients who underwent laparoscopic low anterior resection.
Lee KY1, Park JW2,3, Lee KY1, Cho S1, Kwon YH1, Kim MJ1, Ryoo SB1, Jeong SY1,4, Park KJ1.
Sci Rep. 2019 Feb 19;9(1):2316. doi: 10.1038/s41598-019-38790-6.
Link
2238. Do the Oncological and Surgical Outcomes of Young and Older Women Differ in the Treatment of Colorectal Cancer?
Han EC1, Park JW2,3,4, Kwon YH2, Song I2, Kim JS1, Ryoo SB2,4, Jeong SY2,3,4, Park KJ2,4.
J Womens Health (Larchmt). 2019 Feb;28(2):258-267. doi: 10.1089/jwh.2018.6943. Epub 2018 Nov 27.
Link
2237. Nuclear FGFR2 negatively regulates hypoxia-induced cell invasion in prostate cancer by interacting with HIF-1 and HIF-2.
Lee JE1,2,3, Shin SH1,2,3, Shin HW1,2,3, Chun YS1,3, Park JW4,5,6.
Sci Rep. 2019 Mar 5;9(1):3480. doi: 10.1038/s41598-019-39843-6.
Link
2236. Oxygen sensor FIH inhibits HACE1-dependent ubiquitination of Rac1 to enhance metastatic potential in breast cancer cells.
Kim I1,2, Shin SH1,2,3, Lee JE1,2, Park JW4,5,6.
Oncogene. 2019 May;38(19):3651-3666. doi: 10.1038/s41388-019-0676-y. Epub 2019 Jan 18.
Link